Health
Life-Extending Drugs for Cancer Patients
Patients share their experiences with new cancer treatments, highlighting the impact on quality of life. Daraxonrasib has extended survival months for some but raises questions about tracking survivorship.
Coverage timeline — 2 articles
STAT News
A lung cancer patient speaks out about her cutting-edge treatment: “Research is big on tracking survival stats, but quality of life for survivors — not so much.”
2026-10-23 08:30 UTC
STAT News
Bobby Senaha was among the first patients to use daraxonrasib, a new life-extending drug for pancreatic cancer. His wife shares what those extra months meant to his family.
2026-10-23 08:30 UTC